Department of Virology, Centre Pasteur of Cameroon, Yaoundé, Cameroon; Department of Bacteriology, Centre Pasteur of Cameroon, Yaoundé, Cameroon; Department of Biochemistry, University of Yaoundé, Yaoundé, Cameroon; Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus influenzae, Institut Pasteur, Paris, France.
Department of Bacteriology, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Int J Infect Dis. 2020 Nov;100:12-20. doi: 10.1016/j.ijid.2020.08.040. Epub 2020 Aug 20.
To identifyHaemophilus species and characterize antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon.
Isolates (n = 95) were from patients with RTIs obtained from two Hospitals in Yaoundé, Cameroon. Isolates were identified by biochemical assay, PCR-based method, MALDI-TOF and whole genome sequencing. Antibiotic minimum inhibitory concentrations were determined by E-test.
H. influenzae was the most prevalent species varying from 76.8% to 84.2% according to different methods. The isolates were mainly nontypable (n = 70, 96%). Three isolates of H. influenzae were capsulated (b, e and f). The isolates were genetically diverse and 40 unique sequence types were identified including 11 new ones. Resistance to ampicillin was observed among 55.3% (52/94) and 9% (14/52) produced TEM-1 β-lactamase. PBP3 mutations occurred in 57.7% of ampicillin resistant isolates (30/52). Eleven isolates were chloramphenicol resistant with 80% producing chloramphenicol acetyltransferase (8/10). Four Haemophilus isolates were rifampicin resistant with two mutations in rpoB gene. Five isolates were ciprofloxacin resistant and harbored mutations in the quinolone resistance determining regions of gyrA and parC genes.
H. influenzae isolates are highly diverse and show high levels of antibiotic resistance. H. influenzae serotype b is still circulating in the post-vaccination era.
鉴定来自喀麦隆呼吸道感染(RTI)患者的流感嗜血杆菌属物种,并对其抗菌药物敏感性进行特征分析。
从喀麦隆雅温得的两家医院的 RTI 患者中获得了 95 株分离株。通过生化分析、基于 PCR 的方法、基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)和全基因组测序对分离株进行鉴定。采用 E 试验法测定抗生素最小抑菌浓度。
根据不同方法,流感嗜血杆菌是最常见的物种,比例在 76.8%至 84.2%之间。这些分离株主要是非典型(n=70,96%)。3 株流感嗜血杆菌具有荚膜(b、e 和 f)。这些分离株具有遗传多样性,共鉴定出 40 个独特的序列型,包括 11 个新序列型。55.3%(52/94)和 9%(14/52)的分离株对氨苄西林耐药,且分别有 57.7%(30/52)和 90%(47/52)的分离株产生 TEM-1β-内酰胺酶。氨苄西林耐药分离株中有 57.7%(30/52)发生了 PBP3 突变。11 株分离株对氯霉素耐药,其中 80%(8/10)产生氯霉素乙酰转移酶。4 株流感嗜血杆菌对利福平耐药,rpoB 基因有 2 个突变。5 株分离株对环丙沙星耐药,gyrA 和 parC 基因喹诺酮耐药决定区发生突变。
流感嗜血杆菌分离株具有高度多样性,并表现出高水平的抗生素耐药性。b 型流感嗜血杆菌在疫苗接种后时代仍在传播。